Use of Pharmacokinetic Modeling to Design Studies for Pathway-Specific Exposure Model Evaluation
Open Access
- 1 December 2004
- journal article
- Published by American Chemical Society (ACS) in Environmental Health Perspectives
- Vol. 112 (17) , 1697-1703
Abstract
Validating an exposure pathway model is difficult because the biomarker, which is often used to evaluate the model prediction, is an integrated measure for exposures from all the exposure routes and pathways. The purpose of this article is to demonstrate ...Keywords
This publication has 19 references indexed in Scilit:
- URINARY CADMIUM ELIMINATION AS A BIOMARKER OF EXPOSURE FOR EVALUATING A CADMIUM DIETARY EXPOSURE - BIOKINETICS MODELJournal of Toxicology and Environmental Health, Part A, 2001
- Use of a Pharmacokinetic Model to Assess Chlorpyrifos Exposure and Dose in Children, Based on Urinary Biomarker MeasurementsToxicological Sciences, 2001
- Factors influencing total dietary exposures of young childrenJournal of Exposure Science & Environmental Epidemiology, 2000
- Dietary exposure of children in lead-laden environmentsJournal of Exposure Science & Environmental Epidemiology, 2000
- House dust levels of selected insecticides and a herbicide measured by the EL and LWW samplers and comparisons to hand rinses and urine metabolitesJournal of Exposure Science & Environmental Epidemiology, 2000
- A modeling framework for estimating children's residential exposure and dose to chlorpyrifos via dermal residue contact and nondietary ingestion.Environmental Health Perspectives, 2000
- Uncertainty Analysis Methods for Comparing Predictive Models and Biomarkers: A Case Study of Dietary Methyl Mercury ExposureRegulatory Toxicology and Pharmacology, 1998
- Percutaneous absorption of diazinon in humansFood and Chemical Toxicology, 1993
- A Case Report of Intravenous Malathion Injection with Determination of Serum Half-LifeJournal of Toxicology: Clinical Toxicology, 1987
- Diazinon metabolism in the dogBulletin of Environmental Contamination and Toxicology, 1975